title: Rivaroxaban versus enoxaparin after total knee arthroplasty.
authors.forename: Nina Chetty
authors.initials: NC
authors.lastname: Raju
authors.forename: Simon
authors.initials: S
authors.lastname: Dimmitt
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects; D017326:Clinical Trials, Phase III as Topic; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000008:administration & dosage*; D005060:Europe; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D009656:North America; D016032:Randomized Controlled Trials as Topic; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban